Patients in Odisha and neighbouring states will no longer need to travel outside the state for specialised medical investigations, as the All India Institute of Medical Sciences (AIIMS) Bhubaneswar has inaugurated three upgraded, state-of-the-art diagnostic laboratories under its Department of Biochemistry.
The newly launched Antenatal & New-born Screening Laboratory, Immunology Laboratory, and High-Performance Liquid Chromatography (HPLC) Laboratory mark a major leap forward in public healthcare, bringing high-precision, affordable diagnostic services to the region for the first time in a government healthcare institution.
The facilities were formally inaugurated by Prof. (Dr.) Ashutosh Biswas, Executive Director & CEO of AIIMS Bhubaneswar, in the presence of Dr. Dillip Kumar Parida, Dean (Academic); Dr. Prabhas Ranjan Tripathy, Medical Superintendent; and Dr. Manaswini Mangaraj, Dean (Examination) and Head of the Department of Biochemistry.
Detecting What Was Previously Unreachable
Speaking at the inauguration, Dr. Biswas underscored the clinical impact of the new infrastructure, noting that the advanced platforms can detect trace concentrations of biomarkers in complex samples such as urine and cerebrospinal fluid (CSF)—a capability currently unavailable at any other government hospital in Odisha.
Key Upgrades Across the Three Laboratories
- Antenatal & New-born Screening Laboratory: Outfitted with a new Revvity Victor 2D Fluorometer, the lab delivers heightened sensitivity and accuracy for early disease detection. Seven newborn screening parameters have already been standardised and linked to the Hospital Management Information System (HMIS) for seamless online reporting, with screenings for Phenylketonuria (PKU) and Cystic Fibrosis (CF via Immunoreactive Trypsinogen) set to roll out next. For expectant mothers, the lab introduces comprehensive antenatal risk-prediction panels—including dual-marker (free β-hCG and PAPP-A), triple-marker (adding unconjugated estriol), and penta-marker (adding AFP and PlGF) tests—another first for Odisha’s public sector.
- Immunology Laboratory: Upgraded with a Siemens Atellica NEPH 630 Nephelometer, the unit currently runs six essential immunological assays (IgG, IgA, IgM, IgE, C3, and C4) integrated with HMIS. The department plans a major menu expansion to cover IgG subclasses (IgG1–IgG4), kappa and lambda free light chains, Cystatin C, Homocysteine, Lp(a), Transferrin, sTfR, Haptoglobin, Hemopexin, C1 Esterase Inhibitor, α1-Antitrypsin, Ceruloplasmin, β2-Microglobulin, ASO, and RF. Additionally, lymphocyte cross-matching services will soon be introduced to aid solid organ transplant patients.
- HPLC Laboratory: Widely regarded as the gold standard for HbA1c testing in diabetes diagnosis and management, the new high-throughput HPLC analyser makes AIIMS Bhubaneswar the first AIIMS institution in India to procure this specific system.
By combining cutting-edge automation with online HMIS reporting, AIIMS Bhubaneswar aims to drastically cut turnaround times and out-of-pocket expenses, ensuring world-class diagnostic care remains accessible right within Odisha.















